Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 179, Issue 10, 2009, Pages 894-902

  Simoes, Davina C M ^a,c   Xanthou, Georgina ^b   Petrochilou, Kalomira ^a   Panoutsakopoulou, Vily ^b   Roussos, Charis ^a   Gratziou, Christina ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c Thorax Foundation   (Greece)

Author keywords

Human smooth muscle cells; Osteopontin; Remodeling asthma

Indexed keywords

ALLERGEN; COLLAGEN; GELATINASE B; GOB 5 PROTEIN; INTERLEUKIN 13; MESSENGER RNA; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS MUSCLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LUNG; MOUSE; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SUBMUCOSA;

ANIMALS; ASTHMA; BLOTTING, WESTERN; BRONCHIAL HYPERREACTIVITY; CELL GROWTH PROCESSES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GOBLET CELLS; HUMANS; INTERLEUKIN-13; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; OVALBUMIN; RECOMBINANT PROTEINS;

EID: 65649101299     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200807-1081OC     Document Type: Article

References (55)

1. An SS, Bai TR, Bates JHT, Black JL, Brown RH, Brusasco V, Chitano P, Deng L, Dowell M, Eidelman DH, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 2007;29:834-860.
2. Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB. Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med 2007;175:896-904. (Pubitemid 46684699)
3. Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O'Byrne PM, Inman MD. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004;169:860-867. (Pubitemid 38402464)
4. Southam DS, Ellis R, Wattie J, Inman MD. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 2007;119:848-854. (Pubitemid 46527815)
5. Boulet L-P, Turcotte H, Laviolette M, Naud F, Bernier M-C, Martel S, Chakir J. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-1313.
6. Sont JK, Willems LNA, Bel EH, van Krieken JHJM, Vandenbroucke JP, Sterk PJ, and the Ampul Study Group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;159:1043-1051.
7. Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C, Yousem S, Herrera I, Ruiz V, Selman M, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005;2:e251.
8. Takahashi F, Takahashi K, Okazaki T, Maeda K, Ienaga H, Maeda M, Kon S, Uede T, Fukuchi Y. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2001;24:264-271. (Pubitemid 32228374)
9. Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan T-L, Hsueh WA. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996;98:2218-2227. (Pubitemid 26394194)
10. Chaulet H, Desgranges C, Renault M-A, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau A-P. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 2001;89:772-778. (Pubitemid 34633847)
11. Ogata T, Ueyama T, Nomura T, Asada S, Tagawa M, Nakamura T, Takahashi T, Matsubara H, Oh H. Osteopontin is a myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide 3-kinase/Akt pathway. Biochem Biophys Res Commun 2007;359:341-347. (Pubitemid 46880510)
12. Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008;38:489-499.
13. Kazanecki CC, Uzwiak DJ, Denhart DT. Control of osteopontin signaling and function by post-translational phosphorylation and protein folding. J Cell Biochem 2007;102:912-924. (Pubitemid 350036931)
14. Xanthou G, Alissafi T, Semitekolou M, Simoes DCM, Economidou E, Gaga M, Lambrecht BN, Lloyd CM, Panoutsakopoulou V. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007;13:570-578. (Pubitemid 46828486)
15. Kohan M, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy 2007;37:1444-1454. (Pubitemid 47460229)
16. McMillan SJ, Xanthou G, Lloyd CM. Therapeutic administration of Budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy 2005;35:388-396. (Pubitemid 40516668)
17. McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-{beta} antibody: effect on the Smad signaling pathway. J Immunol 2005;174:5774-5780. (Pubitemid 40593221)
18. Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C. Osteopontin blockade prevents fibrosis in a murine chronic model of allergic airway disease [abstract]. Eur Resp J 2007;(Suppl 50):60S.
19. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BLM. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest 1998;101:1468-1478. (Pubitemid 28166845)
20. Simoes DCM, Vassilakopoulos T, Toumpanakis D, Petrochilou K, Roussos C, Papapetropoulos A. Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med 2008;177:1314-1321.
21. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992;72:168-178.
22. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor {beta}. J Exp Med 2001;194:809-822.
23. Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, Ramalingam TR, Thompson RW, Kamanaka M, Flavell RA, Keane-Myers A, et al. IL-13R{alpha}2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 2007;117:2941-2951.
24. Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor {kappa}B-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. J Biol Chem 2003;278:28593-28606. (Pubitemid 36935765)
25. Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, Fujisawa Y, Nishimura O, Fujino M. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175-5180. (Pubitemid 32397102)
26. O'Regan A. The role of osteopontin in lung disease. Cytokine Growth Factor Rev 2003;14:479-488. (Pubitemid 37296021)
27. McParland BE, Macklem PT, Pare PD. Airway wall remodeling: friend or foe? J Appl Physiol 2003;95:426-434.
28. Pare PD. Airway hyperresponsiveness in asthma: geometry is not everything! Am J Respir Crit Care Med 2003;168:913-914.
29. Benayoun L, Druilhe A, Dombret M-C, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003;167:1360-1368. (Pubitemid 36609720)
30. Chetta A, Foresi A, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodeling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111:852-857. (Pubitemid 27171451)
31. Crimi E, Spanevello A, Neri M, Ind PW, Rossi A, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9. (Pubitemid 28071253)
32. Berman JS, Serlin D, Li X, Whitley G, Hayes J, Rishikof DC, Ricupero DA, Liaw L, Goetschkes M, O'Regan AW. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L1311-L1318. (Pubitemid 38656669)
33. Wagers S, Lundblad LKA, Ekman M, Irvin CG, Bates JHT. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol 2004;96:2019-2027.
34. Wagers SS, Haverkamp HC, Bates JHT, Norton RJ, Thompson-Figueroa JA, Sullivan MJ, Irvin CG. Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J Appl Physiol 2007;102:221-230. (Pubitemid 46089770)
35. Shinagawa K, Kojima M. Mouse model of airway remodeling: strain differences. Am J Respir Crit Care Med 2003;168:959-967. (Pubitemid 37267174)
36. Palmans ELS, Kips JC, Pauwels RA. Prolonged Allergen Exposure Induces Structural Airway Changes in Sensitized Rats. Am J Respir Crit Care Med 2000;161:627-635. (Pubitemid 30129477)
37. Lundblad LKA, Thompson-Figueroa J, Allen GB, Rinaldi L, Norton RJ, Irvin CG, Bates JHT. Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med 2007;175:768-774. (Pubitemid 46631787)
38. Lundblad LKA, Thompson-Figueroa J, Allen GB, Rinaldi L, Norton RJ, Irvin CG, Bates JHT. Mucous obstruction and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2008;177:1171-1172.
39. Dolhnikoff M, Morin J, Ludwig MS. Human lung parenchyma responds to contractile stimulation. Am J Respir Crit Care Med 1998;158:1607-1612. (Pubitemid 28536627)
40. Lee PJ, Zhang X, Shan P, Ma B, Lee CG, Homer RJ, Zhu Z, Rincon M, Mossman BT, Elias JA. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 2006;116:163-173. (Pubitemid 43121801)
41. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999;104:777-785. (Pubitemid 29536363)
42. Allahverdian S, Harada N, Singhera GK, Knight DA, Dorscheid DR. Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am J Respir Cell Mol Biol 2008;38:153-160.
43. Becky KEA, Busse WW, Jarjour NN. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 2000;162:1157-1161.
44. Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, Mautino G, D'Accardi P, Bousquet J, Bonsignore G. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998;158:1945-1950. (Pubitemid 29008837)
45. Cho JY, Miller M, McElwain K, McElwain S, Shim JY, Raz E, Broide DH. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA. J Allergy Clin Immunol 2006;117:618-625. (Pubitemid 43340227)
46. Lai C-F, Seshadri V, Huang K, Shao J-S, Cai J, Vattikuti R, Schumacher A, Loewy AP, Denhardt DT, Rittling SR, et al. An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells. Circ Res 2006;98:1479-1489.
47. Leigh R, Ellis R, Wattie J, Southam DS, de Hoogh M, Gauldie J, O'Byrne PM, Inman MD. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002;27:526-535. (Pubitemid 35301806)
48. Schmidt-Weber CB, Blaser K. The role of TGF-[beta] in allergic inflammation. Immunol Allergy Clin North Am 2006;26:233-244.
49. Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R, et al., and the AIRTSG. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007;356:1327-1337.
50. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-687. (Pubitemid 35283958)
51. Panda D, Kundu GC, Lee BI, Peri A, Fohl D, Chackalaparampil I, Mukherjee BB, Li XD, Mukherjee DC, Seides S, et al. Potential roles of osteopontin and alpha Vbeta 3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci USA 1997;94:9308-9313.
52. Gao YA, Agnihotri R, Vary CPH, Liaw L. Expression and characterization of recombinant osteopontin peptides representing matrix metalloproteinase proteolytic fragments. Matrix Biol 2004;23:457-466. (Pubitemid 39576660)
53. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, and Sobue K. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 1998;273:28860-28867. (Pubitemid 28507577)
54. Hirst SJ, Martin JG, Bonacci JV, Chan V, Fixman ED, Hamid QA, Herszberg B, Lavoie J-P, McVicker CG, Moir LM, et al. Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004;114:S2-S17.
55. Myou S, Leff AR, Myo S, Boetticher E, Tong J, Meliton AY, Liu J, Munoz NM, Zhu X. Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J Exp Med 2003;198:1573-1582. (Pubitemid 37467171)